The UK pet pharmaceutical company Royal Hound has partnered with the Fédération Cynologique Internationale (FCI) to publish joint research findings that propose an innovative approach to maintaining canine health. This study aims to present effective management strategies designed to enhance the overall health and welfare of dogs.
The announcement was made in the UK, a hub for veterinary and pet research in Europe, and is based on joint research with the FCI. The research team conducted a comprehensive analysis of the unique characteristics of various breeds and age-specific health issues, developing tailored nutritional solutions and lifestyle improvement strategies. In particular, RoyalHound has committed to providing scientifically backed, customized solutions to address common issues such as joint problems, heart health, and weakened immunity that are often observed in specific age groups.
The research findings highlight appropriate health management strategies tailored to a dog’s age, activity level, and individual characteristics, aiming to enhance their overall quality of life. Building on these results, RoyalHound is preparing to launch new health management products and services designed to help dogs lead happier and healthier lives.
The representative of FCI stated, “This research underscores the significance of a tailored approach that addresses age-specific needs. We will persist in our research and collaborative efforts to enhance the welfare of companion dogs.
Media Contact:
Name: William Brooks
Company name: Royal Hound
E-Mail: [email protected]
Royal Hound
Information contained on this page is provided by an independent third-party content provider. eTrendystock make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]
